ArticlemedRxiv : the preprint server for health sciences2025
Disproportionately Elevated Sulcal Index (DESI): An automatically driven index representing disproportionate subarachnoid space enlargement in brain MRI scans.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
6 authors.
Funding
Abstract
Background: Idiopathic normal pressure hydrocephalus (iNPH) is a reversible cause of dementia in older adults yet remains underdiagnosed due to nonspecific clinical presentation and reliance on invasive confirmatory tests. Conventional MRI biomarkers, including the Evans index and callosal angle, capture ventricular enlargement but incompletely characterize cerebrospinal fluid (CSF) redistribution. Disproportionately enlarged subarachnoid-space hydrocephalus (DESH) features, tight high-convexity sulci and enlarged Sylvian fissures, are more disease-specific but lack standardized quantitative measures. Methods: We developed the Disproportionately Elevated Sulcal Index (DESI), an automated volumetric biomarker quantifying the ratio of Sylvian fissure volume to superior sulcal space volume. T1-weighted MRI scans were acquired from three independent cohorts: the Baltimore Longitudinal Study of Aging (n = 1,032), Johns Hopkins CSF Disorders Clinic (n = 216), and the Placebo-controlled Efficacy of iNPH Shunting trial (n = 94). Preprocessing included N4 bias correction, standard-space registration, and alignment. A U-Net segmentation model with an EfficientNet-B0 encoder delineated Sylvian fissures and sulcal compartments. DESI was computed from 3D reconstructions and evaluated using Dice similarity coefficients, landmark detection error, and classification performance across diagnostic groups. Results: Segmentation achieved ~0.80 DICE for Sylvian fissures; ~0.74 for superior sulci. On external validation, DESI discriminated NPH with DESH from non-DESH NPH with AUC = 0.99, accuracy 97.9%, and from all other groups (healthy controls, Alzheimer's disease, vascular dementia) with perfect classification (AUC = 1.00, 100% sensitivity and specificity at threshold = 4.83). In cognitively normal adults, DESI showed only a modest age-related increase and no sex differences, confirming specificity for hydrocephalic pathology. Conclusion: DESI is a robust, fully automated MRI biomarker that sensitively detects CSF redistribution characteristic of DESH in iNPH. By outperforming traditional indices and achieving near-perfect diagnostic accuracy across independent cohorts, DESI offers a noninvasive tool for early detection, patient selection for shunting, and longitudinal monitoring of disease progression.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.